Maternal Health and Vitiligo: First Scoping Review Protocol
Conexiant
September 12, 2025
A scoping review protocol was published in BMJ Open to examine pregnancy outcomes in patients with vitiligo.
The review will assess maternal and neonatal risks, including preeclampsia, gestational diabetes, and stillbirth.
The study will follow the Arksey and O’Malley framework and search PubMed and Scopus for English-language studies.
Data extraction will include study design, patient population, and outcomes, with results synthesized narratively.
The researchers aim to identify research gaps and enhance clinical relevance by consulting various healthcare professionals.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: